{"product_id":"wegovy-semaglutide-injection-pen-1-7-mg-1-ct-novo-nordisk","title":"Wegovy (Semaglutide) Injection Pen 1.7 mg, 1 Ct - Novo Nordisk","description":"\u003ch2\u003e\u003cstrong\u003eWegovy 1.7 mg (Semaglutide)\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eWegovy 1.7 mg is a prescription glucagon-like peptide-1 (GLP-1) receptor agonist pen used as the \u003cstrong\u003efourth step in the standard 16-week dose-escalation schedule\u003c\/strong\u003e for chronic weight management. It is indicated for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAdults with obesity (BMI ≥30 kg\/m²)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAdults who are overweight (BMI ≥27 kg\/m²) with at least one weight-related comorbidity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eReduction of cardiovascular risk in adults with established cardiovascular disease and BMI ≥27 kg\/m²\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 1.7 mg dose is typically administered once weekly during \u003cstrong\u003eweeks 13–16\u003c\/strong\u003e as the final step-up dose before transitioning to the maintenance dose of 2.4 mg.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eKey Benefits\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eFinal titration dose before reaching maintenance therapy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHelps the body adapt gradually to reduce gastrointestinal side effects\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSupports continued appetite suppression and improved satiety\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePrepares patients for transition to full therapeutic effect at 2.4 mg dose\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eContributes to structured, clinically guided weight loss progression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eOnce-weekly convenient dosing\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eClinical Importance in Treatment Plan\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eFourth and final escalation step in the Wegovy titration schedule\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eUsed during weeks 13–16 before maintenance dosing begins at week 17\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHelps optimize tolerability before reaching maximum therapeutic dose\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eWhen continued to 2.4 mg maintenance dose, semaglutide has shown up to \u003cstrong\u003e15.6% mean body weight reduction\u003c\/strong\u003e in clinical trials (STEP program)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAs part of full regimen, associated with a \u003cstrong\u003e20% reduction in major adverse cardiovascular events\u003c\/strong\u003e in high-risk patients (SELECT trial)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eAdministration\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAdminister once weekly via subcutaneous injection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eInjection sites:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAbdomen\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThigh\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eUpper arm\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eCan be taken at any time of day\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eWith or without meals\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eDose must be followed as per physician guidance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eComposition\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eEach prefilled pen contains:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eSemaglutide: \u003cstrong\u003e6.8 mg in 3 mL (2.27 mg\/mL)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eUse strictly as prescribed by a qualified physician\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIntended for weeks 13–16 in the standard titration schedule\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eDo not increase or adjust dose without medical supervision\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eLegal Disclaimer\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eTheVitaminShop.pk is not the manufacturer of this product. Product information may be updated by the manufacturer without notice, and actual packaging may differ from website details. This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before use and read the product label carefully.\u003c\/p\u003e","brand":"Novo Nordisk","offers":[{"title":"1 x 3mL pen \u0026 4 disposable needles \/ Lahore Only","offer_id":54550967353716,"sku":null,"price":54218.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0890\/8816\/4212\/files\/Wegovy_Semaglutide_InjectionPen1.7mg_1Ct-NovoNordisk.webp?v=1777403764","url":"https:\/\/thevitaminshop.pk\/products\/wegovy-semaglutide-injection-pen-1-7-mg-1-ct-novo-nordisk","provider":"The Vitamin Shop","version":"1.0","type":"link"}